Showing 81 - 100 results of 109 for search 'SAABRON PRESS', query time: 0.12s Refine Results
  1. 81
    The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study

    The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study by Agoston Gyula Szabo, Katrine Fladeland Iversen, Sören Möller, Torben Plesner

    Published 2019-08-01
    “…SAABRON PRESS…”
    Get full text
    Article
  2. 82
    Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: In vivo T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Acute Leukemia Working Party-European Society for Blood and Marrow Transplant Study

    Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: In vivo T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Ac... by Ali Bazarbachi, Myriam Labopin, Giorgia Battipaglia, Azedine Djabali, Edouard Forcade, William Arcese, Gerard Socié, Didier Blaise, Joerg Halter, Sabine Gerull, Jan J. Cornelissen, Patrice Chevallier, Johan Maertens, Nicolaas Schaap, Jean El-Cheikh, Jordi Esteve, Arnon Nagler, Mohamad Mohty

    Published 2019-03-01
    “…SAABRON PRESS…”
    Get full text
    Article
  3. 83
    Predicting Immuno-Metabolic Complications After Allogeneic Hematopoietic Cell Transplant with the Cytokine Interleukin-33 (IL-33) and its Receptor Serum-Stimulation 2 (ST2)

    Predicting Immuno-Metabolic Complications After Allogeneic Hematopoietic Cell Transplant with the Cytokine Interleukin-33 (IL-33) and its Receptor Serum-Stimulation 2 (ST2) by Uttam K. Rao, Brian G. Engelhardt

    Published 2020-05-01
    “…SAABRON PRESS…”
    Get full text
    Article
  4. 84
    Health Disparities Experienced by Hispanic Americans with Multiple Myeloma: A Systematic Review

    Health Disparities Experienced by Hispanic Americans with Multiple Myeloma: A Systematic Review by Andrea Anampa-Guzmán, Sara Taveras Alam, Inas Abuali, Samer Al Hadidi

    Published 2022-12-01
    “…SAABRON PRESS…”
    Get full text
    Article
  5. 85
    The Impact of Achieving Complete Remission Prior to Allogeneic Stem Cell Transplantation on Progression-Free Survival in Hodgkin Lymphoma

    The Impact of Achieving Complete Remission Prior to Allogeneic Stem Cell Transplantation on Progression-Free Survival in Hodgkin Lymphoma by Nadira Duraković, Zinaida Perić, Sandra Bašić Kinda, Lana Desnica, Dino Dujmović, Ivo Radman Livaja, Ranka Serventi Seiwerth, Igor Aurer, Radovan Vrhovac

    Published 2021-07-01
    “…SAABRON PRESS…”
    Get full text
    Article
  6. 86
    How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms

    How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms by Carmelo Gurnari, Zhuoer Xie, Amer M. Zeidan

    Published 2022-12-01
    “…SAABRON PRESS…”
    Get full text
    Article
  7. 87
    The Management of a Comprehensive Cancer Center during the First Six Months of the COVID-19 Pandemic in the South of France: Lessons from the Paoli-Calmettes Institute’s Experience

    The Management of a Comprehensive Cancer Center during the First Six Months of the COVID-19 Pandemic in the South of France: Lessons from the Paoli-Calmettes Institute’s Experience... by Didier Blaise, Pierre Berger, Djamel Mokart, Jacques Camerlo, Emmanuelle Fougereau, Marc Giovannini, Gilles Houvenaeghel, Olivier Turrini, Christian Chabannon, Gilles Piana, Isabelle Brenot-Rossi, Agnès Tallet, Anthony Gonçalves, Aude Charbonnier, Norbert Vey, Sabrina Grossi, Patrice Viens

    Published 2021-09-01
    “…SAABRON PRESS…”
    Get full text
    Article
  8. 88
    Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-versus-Host Disease Prophylaxis

    Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as... by Maria Queralt Salas, Arjun Datt Law, Wilson Lam, Zeyad Al-Shaibani, David Loach, Dennis (Dong Hwan) Kim, Fotios V. Michelis, Santhosh Thyagu, Rajat Kumar, Jeffrey Howard Lipton, Jonas Mattsson, Auro Viswabandya

    Published 2019-06-01
    “…SAABRON PRESS…”
    Get full text
    Article
  9. 89
    Comparison of Conventional Cyclophosphamide versus Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched-Related Donor Transplantation

    Comparison of Conventional Cyclophosphamide versus Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched-Related Donor Transplantation by Raheel Iftikhar, Qamar un Nisa Chaudhry, Tariq Mehmood Satti, Syed Kamran Mahmood, Tariq Ghafoor, Ghassan Umair Shamshad, Nighat Shahbaz, Mehreen Ali Khan, Tariq Azam Khattak, Jahanzeb Rehman, Muhammad Farhan, Saima Humayun, Humera Haq, Syeda Ammaara Anwaar Naqvi, Faiz Anwer, Humayoon Shafique Satti, Parvez Ahmed

    Published 2020-05-01
    “…SAABRON PRESS…”
    Get full text
    Article
  10. 90
    Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation

    Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation by Sayako Yuda, Shigeo Fuji, Bipin Savani, Katie S. Gatwood

    Published 2022-07-01
    “…SAABRON PRESS…”
    Get full text
    Article
  11. 91
    Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma

    Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly D... by Kristian T. Andersen, Maja Hinge, Agoston Gyula Szabo, Erik Segel, Tina Ormstrup, Paw C. Holdgaard, Niels Pallisgaard, Gitte Kerndrup, Torben Plesner

    Published 2020-01-01
    “…SAABRON PRESS…”
    Get full text
    Article
  12. 92
    The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia

    The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia by Obada Ababneh, Hassan Abushukair, Aref Qarqash, Sebawe Syaj, Samer Al Hadidi

    Published 2022-05-01
    “…SAABRON PRESS…”
    Get full text
    Article
  13. 93
    Salvage Therapy after Allogeneic Hematopoietic Cell Transplantation: Targeted and Low-Intensity Treatment Options in Myelodysplastic Syndrome and Acute Myeloid Leukemia

    Salvage Therapy after Allogeneic Hematopoietic Cell Transplantation: Targeted and Low-Intensity Treatment Options in Myelodysplastic Syndrome and Acute Myeloid Leukemia by Katie Culos, Michael Byrne

    Published 2019-05-01
    “…SAABRON PRESS…”
    Get full text
    Article
  14. 94
    Emerging Therapies for the Myelodysplastic Syndromes

    Emerging Therapies for the Myelodysplastic Syndromes by Jonathan Canaani

    Published 2019-12-01
    “…SAABRON PRESS…”
    Get full text
    Article
  15. 95
    The CD34+ Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors

    The CD34+ Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors by M. Remberger, B. Grønvold, M. Ali, J. Mattsson, T. Egeland, K. U. Lundin, A. Myhre, I. Abrahamsen, D. Heldal, I. Dybedal, G. E. Tjønnfjord, T. Gedde-Dahl, Y. Fløisand

    Published 2020-03-01
    “…SAABRON PRESS…”
    Get full text
    Article
  16. 96
    ‘Standing on the Shoulders of the Giants’: Dr Rainer Storb

    ‘Standing on the Shoulders of the Giants’: Dr Rainer Storb by Mohamad Mohty, Rainer Storb

    Published 2022-08-01
    “…SAABRON PRESS…”
    Get full text
    Article
  17. 97
    Passive Immunity Should and Will Work for COVID-19 for Some Patients

    Passive Immunity Should and Will Work for COVID-19 for Some Patients by Nevio Cimolai

    Published 2021-04-01
    “…SAABRON PRESS…”
    Get full text
    Article
  18. 98
    The Impact of First Complete Remission by PET-CT and Time to Next Treatment on Survival of Follicular Lymphoma Patients

    The Impact of First Complete Remission by PET-CT and Time to Next Treatment on Survival of Follicular Lymphoma Patients by Tran-Der Tan, Lun-Wei Chiou, Mau-Ching Wu, Jia-Shing Wu, Ming-Yuan Lee, Yu-Yi Huang, Shing-Su Chen

    Published 2019-09-01
    “…SAABRON PRESS…”
    Get full text
    Article
  19. 99
    Another Year to Celebrate Advances in Clinical Hematology

    Another Year to Celebrate Advances in Clinical Hematology by Mohamad Mohty, Junia V. Melo

    Published 2023-03-01
    “…SAABRON PRESS…”
    Get full text
    Article
  20. 100
    The Evolving Landscape of Myelodysplastic Syndrome Prognostication

    The Evolving Landscape of Myelodysplastic Syndrome Prognostication by Jacob Shreve, Aziz Nazha

    Published 2020-04-01
    “…SAABRON PRESS…”
    Get full text
    Article

Search Tools: